SCHEMBL10367448

SCHEMBL10367448

CC(C)(C)N(C(=O)O)C1CCN(Cc2ccccc2)C1.CC(C)(C)N(C(=O)O)C1CCNC1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
▸ OPRM1 P35372 3/20 0.49
▸ SIGMAR1 Q99720 4/20 0.47
▸ CHRM2 P08172 5/20 0.45
▸ CHRM3 P20309 5/20 0.45
▸ KCNH2 Q12809 1/20 0.44
▸ HTR2A P28223 3/20 0.44
▸ HTR2C P28335 3/20 0.44
▸ HTR2B P41595 3/20 0.44
▸ DRD2 P14416 2/20 0.44
▸ CHRM4 P08173 1/20 0.43
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ ACHE P22303 2/20 0.42
▸ BCHE P06276 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10367449 0.91 OPRM1 (0.47) OPRM1SIGMAR1CHRM2CHRM3KCNH2
SCHEMBL1307812 0.90 OPRM1 (0.55) OPRM1SIGMAR1CHRM2CHRM3KCNH2
SCHEMBL10901330 0.84 KMT2A (0.47) OPRM1DRD2CHRM4MEN1KMT2A
SCHEMBL10901335 0.83 OPRM1 (0.40) OPRM1SIGMAR1CHRM2CHRM3KCNH2
SCHEMBL20544083 0.83 KDM4E (0.55) OPRM1CHRM2CHRM3MEN1KMT2A
SCHEMBL20544081 0.83 KDM4E (0.55) OPRM1CHRM2CHRM3MEN1KMT2A
SCHEMBL1306000 0.83 OPRM1 (0.61) OPRM1SIGMAR1CHRM2CHRM3KCNH2
SCHEMBL5171694 0.78 OPRM1 (0.57) OPRM1SIGMAR1CHRM3KCNH2DRD2
SCHEMBL1062230 0.78 OPRM1 (0.56) OPRM1SIGMAR1CHRM2CHRM3KCNH2
SCHEMBL1207106 0.77 OPRM1 (0.54) OPRM1SIGMAR1CHRM2CHRM3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0172651-B1 Substituted-9-fluoro-3-methyl-7-oxo-2,3-dihydro-7H-pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acids; substituted-5-amino-6-fluoro-4-oxo-1,4-dihydroquinoline-3-carboxylic acids; substituted-5-amino-6-fluoro-1,4-dihydro-4-oxo-1,8-naphthyridine-3-carboxylic acids; derivatives thereof; pharmaceutical compositions comprising the compounds; and processes for producing the compounds WARNER-LAMBERT COMPANY (US) 1990-02-07 — — EP disclosed
Send feedback